Chapter 27: Drugs for Lipid Disorders

Slides:

Advertisements

Similar presentations

Agents Used in the Treatment of Hyperlipidemia

Advertisements

© 2012 Chevron Healthy Heart Program Cholesterol Presenter’s Name and Title Location and Date.

Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.

Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium sized arteries.

SWBAT: Describe the structure of steroids Chapter 15 Cholesterol & Steroid Hormones.

Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.

Lowering Your Cholesterol University Medical Center Community Education Program.

Kristin Miller Caleb Conrad 13.9 What Are Steroids.

Hyperlipidemia Hyperlipidemia and hyperlipoproteinemia are general terms for elevated concentrations of lipids and lipoproteins in the blood. hypercholesterolemia.

Figure A--1 Thomas L. Floyd Digital Fundamentals, 8e Copyright ©2003 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved.

Chapter 21 Agents Used in the Treatment of Hyperlipidemia.

Drugs Used to Treat Dyslipidemias Chapter 22 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.

HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.

50 Drugs that Help Normalize Cholesterol & Triglyceride Levels

Atorvastatin Calcium Atorvastatin Calcium is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of.

Drugs for Lipid Disorders

Formative Test.

Intestinal Villi.

Applied Therapeutics Dr. Riyadh Mustafa Al-Salih

Chapter 34: Drugs for Viral Infections

Chapter 40: Drugs for Pancreatic Disorders

Chapter 13: Drugs Affecting the Autonomic Nervous System

Lipids & Lipoproteins Part 2.

Chapter 35: Antineoplastic Drugs

Chapter 38: Drugs for Nutritional Disorders

Chapter 29: Drugs for Pulmonary Disorders

Cardiovascular System

Chapter 13: Drugs Affecting the Autonomic Nervous System

Chapter 36: Drugs for Peptic Ulcer Disease

Chapter 43: Drugs for Renal Disorders and Diuretic Therapy

Chapter 35: Antineoplastic Drugs

Antilipemic Agents Lilley Pharmacology Text: Chapter 27

Chapter 15: Drugs for Seizures

Chapter 21: Drugs for Hypertension

Chapter 18: Drugs for Degenerative Diseases of the Central Nervous System Pharmacology for Nurses: A Pathophysiologic Approach, 1/e Michael Patrick Adams.

Chapter 47: Drugs for Skin Disorders

Chapter 22: Drugs for Heart Failure

Figure 11.2 Evaluation of Illustrations

Chapter 21: Drugs for Hypertension

Chapter 24: Drugs for Coagulation Disorders

Figure 15.1 Collaborative Professional Development

Chapter 27: Drugs for Lipid Disorders

Chapter 48: Drugs for Eye and Ear Disorders

DISCUSSION POINTS Chapter 18: Drugs for Degenerative Diseases of the Central Nervous System Pharmacology for Nurses: A Pathophysiologic Approach, 1/e Michael.

Chapter 45: Drugs for Muscle Spasms and Spasticity

Chapter 40: Drugs for Pancreatic Disorders

Chapter 37: Drugs for Bowel Disorders, Nausea, and Vomiting

Figure 4--2 Mrs. Mast’s Unit Plan for “The Three Bears”

Chapter 24: Drugs for Coagulation Disorders

Chapter 15: Drugs for Seizures

Figure 15.1 Collaborative Professional Development

DISCUSSION POINTS Chapter 25: Drugs for Angina Pectoris, Myocardial Infarction, and Cerebrovascular Accident Pharmacology for Nurses: A Pathophysiologic.

Chapter 47: Drugs for Skin Disorders

Chapter 19: Drugs for the Control of Pain

Chapter 43: Drugs for Renal Disorders and Diuretic Therapy

Chapter 45: Drugs for Muscle Spasms and Spasticity

Chapter 37: Drugs for Bowel Disorders, Nausea, and Vomiting

Chapter 23: Drugs for Dysrhythmias

Chapter 29: Drugs for Pulmonary Disorders

Lecture 5b 7 Feb 2011 Atherosclerosis-Nutritional intervention-

Major classes of drugs to reduce lipids

Figure 11.2 Evaluation of Illustrations

Chapter 23: Drugs for Dysrhythmias

Titration activities from baseline up to 6 and 12 months follow-up in nurse-coordinated care (NCC) versus usual care patients. X-as: patients (percentage),

Lipoproteins Macromolecular complexes in the blood that transport lipids Apolipoproteins Proteins on the surface of lipoproteins; they play critical.

Chapter 36: Drugs for Peptic Ulcer Disease

Chapter 38: Drugs for Nutritional Disorders

Chapter 19: Drugs for the Control of Pain

ATP III Guidelines Drug Therapy FUTURE RESEARCH.

Section 6: Update on lipid treatment guidelines

Presentation transcript:

Chapter 27: Drugs for Lipid Disorders DISCUSSION POINTS Chapter 27: Drugs for Lipid Disorders Pharmacology for Nurses: A Pathophysiologic Approach, 1/e Michael Patrick Adams Dianne L. Josephson Leland Norman Holland, Jr. Copyright ©2005 by Pearson Education, Inc. Upper Saddle River, New Jersey 07458 All rights reserved.

Types of Lipids - Triglycerides - Phospholipids - Steroids Pharmacology for Nurses: A Pathophysiologic Approach, 1/e Michael Patrick Adams Dianne L. Josephson Leland Norman Holland, Jr. Copyright ©2005 by Pearson Education, Inc. Upper Saddle River, New Jersey 07458 All rights reserved.

- High-density lipoprotein (HDL) - Low-density lipoprotein (LDL) Lipoproteins - High-density lipoprotein (HDL) - Low-density lipoprotein (LDL) - Very low-density lipoprotein (VLDL) Pharmacology for Nurses: A Pathophysiologic Approach, 1/e Michael Patrick Adams Dianne L. Josephson Leland Norman Holland, Jr. Copyright ©2005 by Pearson Education, Inc. Upper Saddle River, New Jersey 07458 All rights reserved.

Discuss the teaching needs for the patient in the following scenario: A client has been taking atorvastatin calcium (Lipitor) 80 mg daily for eight weeks. The blood lipid levels are still elevated. The physician finds out the client is eating a lot of foods high in cholesterol and saturated fats. The client states, “I thought that ‘pill’ was to take care of everything.” Pharmacology for Nurses: A Pathophysiologic Approach, 1/e Michael Patrick Adams Dianne L. Josephson Leland Norman Holland, Jr. Copyright ©2005 by Pearson Education, Inc. Upper Saddle River, New Jersey 07458 All rights reserved.

Discuss the rationale for patients requiring an antihyperlipidemic agent even though they have reduced their dietary intake of cholesterol and saturated fats. Pharmacology for Nurses: A Pathophysiologic Approach, 1/e Michael Patrick Adams Dianne L. Josephson Leland Norman Holland, Jr. Copyright ©2005 by Pearson Education, Inc. Upper Saddle River, New Jersey 07458 All rights reserved.

HMG CoA reductase inhibitor - Best time of day to take - Reason for this timing Pharmacology for Nurses: A Pathophysiologic Approach, 1/e Michael Patrick Adams Dianne L. Josephson Leland Norman Holland, Jr. Copyright ©2005 by Pearson Education, Inc. Upper Saddle River, New Jersey 07458 All rights reserved.

The rationale why patients should not self-medicate with OTC niacin to lower blood lipid levels Pharmacology for Nurses: A Pathophysiologic Approach, 1/e Michael Patrick Adams Dianne L. Josephson Leland Norman Holland, Jr. Copyright ©2005 by Pearson Education, Inc. Upper Saddle River, New Jersey 07458 All rights reserved.

The reasons that patients must wait a month or more to see the effects of lipid-lowering agents Pharmacology for Nurses: A Pathophysiologic Approach, 1/e Michael Patrick Adams Dianne L. Josephson Leland Norman Holland, Jr. Copyright ©2005 by Pearson Education, Inc. Upper Saddle River, New Jersey 07458 All rights reserved.

The rationale behind why HMG CoA reductase inhibitors are contraindicated in patients with liver dysfunction Pharmacology for Nurses: A Pathophysiologic Approach, 1/e Michael Patrick Adams Dianne L. Josephson Leland Norman Holland, Jr. Copyright ©2005 by Pearson Education, Inc. Upper Saddle River, New Jersey 07458 All rights reserved.